IDiyas

For the Inventor, By the Inventor

Lörrach, Germany

Gebhard Thoma

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 165(Granted Patents)


Location History:

  • Basel, CH (2012)
  • Lorrach, DE (2016 - 2022)
  • Lörrach, DE (2002 - 2024)

Company Filing History:

goldMedal17 out of 3,923 
 
Novartis Ag
 patents
silverMedal1 out of 123 
 
Astex Therapeutics Limited
 patents

Years Active: 2002-2024

Loading Chart...
Loading Chart...
18 patents (USPTO):
1. 12157737 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof (2024-12-03),
2. 11932630 - Heteroaryl aminopropanol derivatives (2024-03-19),
3. 11708366 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof (2023-07-25),
4. 11274080 - Diamino pyridine derivatives (2022-03-15),
5. 10570096 - Diamino pyridine derivatives (2020-02-25),
6. 9315500 - Bicyclic heteroaryl cycloalkyldiamine derivatives (2016-04-19),
7. 9290481 - Monocyclic heteroaryl cycloalkyldiamine derivatives (2016-03-22),
8. 8431589 - 2,4-diaminopyrimidine derivatives (2013-04-30),
9. 8324225 - Pyrrolopyrimidine compounds and their uses (2012-12-04),
10. 8283356 - 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors (2012-10-09),
11. 7943627 - 2,4-diaminopyrimidine derivatives (2011-05-17),
12. 7671078 - Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitors (2010-03-02),
13. 7671063 - 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors (2010-03-02),
14. 7666877 - Ergoline derivatives (2010-02-23),
15. 7399771 - Piperidine derivatives as CCR5 inhibitors (2008-07-15),

Title: Gebhard Thoma: Innovator in Pharmaceutical Chemistry

Introduction

Gebhard Thoma is a distinguished inventor based in Lörrach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 18 patents. His work focuses on developing innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents are "Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof," which provides a compound of formula (I) or a pharmaceutically acceptable salt thereof. Another notable patent is "Heteroaryl aminopropanol derivatives," which includes a method for manufacturing the compounds and their therapeutic uses. This invention also offers a combination of pharmacologically active agents and a pharmaceutical composition.

Career Highlights

Throughout his career, Gebhard Thoma has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Astex Therapeutics Limited. His expertise in drug development has led to advancements in various therapeutic areas.

Collaborations

He has collaborated with notable professionals in the field, including Rudolf Duthaler and Rolf Baenteli. These partnerships have contributed to the success of his innovative projects.

Conclusion

Gebhard Thoma's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…